• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comments on "Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization".

作者信息

Emami Shahram, Shayanfar Ali

机构信息

School of Pharmacy, Urmia University of Medical Sciences, Urmia, Iran.

Pharmaceutical Analysis Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2021 May;11(3):578-579. doi: 10.34172/apb.2021.067. Epub 2020 May 26.

DOI:10.34172/apb.2021.067
PMID:34513634
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421615/
Abstract
摘要

相似文献

1
Comments on "Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization".关于“阿托伐他汀钙共结晶提高溶出度”的评论
Adv Pharm Bull. 2021 May;11(3):578-579. doi: 10.34172/apb.2021.067. Epub 2020 May 26.
2
Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.阿托伐他汀钙共结晶对溶出度的增强作用
Adv Pharm Bull. 2019 Oct;9(4):559-570. doi: 10.15171/apb.2019.064. Epub 2019 Oct 24.
3
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.采用超临界抗溶剂（SAS）法制备、表征及体内评价无定形阿托伐他汀钙纳米粒
Eur J Pharm Biopharm. 2008 Jun;69(2):454-65. doi: 10.1016/j.ejpb.2008.01.007. Epub 2008 Jan 18.
4
Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.有序介孔二氧化硅对模型难溶性药物阿托伐他汀的溶出增强作用：以MSF和SBA - 15作为药物载体的比较
Expert Opin Drug Deliv. 2016;13(2):171-81. doi: 10.1517/17425247.2015.1111335. Epub 2015 Dec 4.
5
Atorvastatin solid dispersion for bioavailability enhancement.用于提高生物利用度的阿托伐他汀固体分散体。
J Adv Pharm Technol Res. 2016 Jan-Mar;7(1):22-6. doi: 10.4103/2231-4040.169873.
6
Stable amorphous binary systems of glipizide and atorvastatin powders with enhanced dissolution profiles: formulation and characterization.具有改善溶出曲线的格列吡嗪和阿托伐他汀粉末的稳定无定形二元体系：制剂与表征
Pharm Dev Technol. 2017 Feb;22(1):13-25. doi: 10.3109/10837450.2015.1125921. Epub 2015 Dec 27.
7
Effect of ball milling on the physicochemical properties of atorvastatin calcium sesquihydrate: the dissolution kinetic behaviours of milled amorphous solids.球磨对阿托伐他汀钙倍半水合物理化性质的影响：球磨无定形固体的溶解动力学行为
J Pharm Pharmacol. 2017 Jan;69(1):15-22. doi: 10.1111/jphp.12636. Epub 2016 Oct 26.
8
Dissolution enhancement of atorvastatin calcium by co-grinding technique.采用共研磨技术增强阿托伐他汀钙的溶出度。
Drug Deliv Transl Res. 2016 Aug;6(4):380-91. doi: 10.1007/s13346-015-0271-x.
9
Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation.阿托伐他汀和依折麦布共处理提高溶出度：体外和体内相关性。
AAPS PharmSciTech. 2021 Jan 31;22(2):59. doi: 10.1208/s12249-021-01925-y.
10
In silico screening of dicarboxylic acids for cocrystallization with phenylpiperazine derivatives based on both cocrystallization propensity and solubility advantage.基于共结晶倾向和溶解度优势，对二元羧酸与苯基哌嗪衍生物共结晶进行计算机模拟筛选。
J Mol Model. 2017 Apr;23(4):136. doi: 10.1007/s00894-017-3287-y. Epub 2017 Mar 27.

本文引用的文献

1
Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization.阿托伐他汀钙共结晶对溶出度的增强作用
Adv Pharm Bull. 2019 Oct;9(4):559-570. doi: 10.15171/apb.2019.064. Epub 2019 Oct 24.
2
Pharmaceutical cocrystals: from serendipity to design to application.药物共晶：从偶然发现到设计到应用。
Drug Discov Today. 2019 Mar;24(3):796-804. doi: 10.1016/j.drudis.2018.11.023. Epub 2018 Dec 3.
3
Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.吡罗昔康与酚类共晶形成物的共晶：制备、表征和溶解性能。
Pharm Dev Technol. 2019 Feb;24(2):199-210. doi: 10.1080/10837450.2018.1455210. Epub 2018 Apr 4.
4
Solid-state, triboelectrostatic and dissolution characteristics of spray-dried piroxicam-glucosamine solid dispersions.喷雾干燥吡罗昔康 - 氨基葡萄糖固体分散体的固态、摩擦静电及溶解特性
Colloids Surf B Biointerfaces. 2016 Oct 1;146:841-51. doi: 10.1016/j.colsurfb.2016.07.032. Epub 2016 Jul 16.
5
Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid.共形成物化学计量比对药物共晶体溶出度的影响：卡马西平/4-氨基苯甲酸的三种共晶体
Mol Pharm. 2016 Mar 7;13(3):990-5. doi: 10.1021/acs.molpharmaceut.5b00843. Epub 2016 Feb 3.
6
Synthesis and characterisation of glucosamine-NSAID bioconjugates.氨基葡萄糖-非甾体抗炎药生物共轭物的合成与表征
Org Biomol Chem. 2014 Nov 7;12(41):8325-35. doi: 10.1039/c4ob01681e. Epub 2014 Sep 12.
7
Coamorphous atorvastatin calcium to improve its physicochemical and pharmacokinetic properties.制备无定形态阿托伐他汀钙以改善其理化性质和药代动力学性质。
J Pharm Pharm Sci. 2013;16(4):577-87. doi: 10.18433/j3xs4s.
8
Pharmaceutical cocrystals and poorly soluble drugs.药物共晶和难溶性药物。
Int J Pharm. 2013 Aug 30;453(1):101-25. doi: 10.1016/j.ijpharm.2012.10.043. Epub 2012 Dec 1.
9
Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products.阿托伐他汀及其强制降解产物的液相色谱/质谱研究。
Rapid Commun Mass Spectrom. 2008;22(5):613-22. doi: 10.1002/rcm.3403.